Emel Akan is a senior White House correspondent for The Epoch Times, where she covers the policies of the Trump administration. Previously, she reported on the Biden administration and the first term of President Trump. Before her journalism career, she worked in investment banking at JPMorgan. She holds an MBA from Georgetown University.
China’s iron grip on supply of critical drug ingredients has been years in the making, driven by Beijing’s strategic plan to dominate the pharma industry
Washington is reportedly asking countries to ban transshipments, help stop China from dumping cheap goods on the global market, in exchange for tariff cuts.
Beijing has already employed various familiar tactics from its playbook to retaliate against the United States, including spreading anti-American propaganda.
A White House official confirmed that the new tariff rate on Chinese products now totals 145 percent, not 125 percent as the president suggested earlier.